GlassScriptPhysician profile
Cara A Guth
NPI 1992177182
$650.72
in general payments reported to CMS, 2019-2025
18 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $473 · 2022: $53.67 · 2023: $21.21 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $139.51 | 2021 | |
| Amgen INC. | $89.52 | 2021 | |
| Globus Medical, INC. | $61.95 | 2025 | Alvue |
| Mallinckrodt Hospital Products INC. | $54.60 | 2021 | |
| Radius Health, INC. | $39.90 | 2021 | |
| Bioventus LLC | $36.74 | 2022 | |
| Glaxosmithkline, LLC. | $32.26 | 2021 | |
| Heraeus Medical, LLC. | $23.21 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.48 | 2025 | Exparel |
| Kci USA, INC. | $21.21 | 2023 | Prevena |
| Abbvie INC. | $19.85 | 2021 | |
| Fidia Pharma USA INC. | $19.57 | 2025 | Hymovis |
| Pfizer INC. | $17.08 | 2021 | |
| Ethicon US, LLC | $16.93 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.03 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.94 | 2021 | |
| Ucb, INC. | $13.40 | 2021 | |
| Lilly USA, LLC | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Guth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.